Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...

The purpose of the study was to determine the screening performance of prenatal reflex DNA screening for trisomies 21 (T21), 18 (T18), and 13 (T13) as part of a routine service at five hospitals.

In an ideal world, the oncologist meeting a patient newly diagnosed with nonsmall-cell lung cancer (NSCLC) will already have information on genetic mutations in the tumor, so can initiate targeted ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

EDMONTON, AB, June 30, 2022 /PRNewswire/ - Nanostics Inc., a precision health diagnostics company, today announces positive data from a pre-biopsy clinical validation study of its ClarityDX Prostate ® ...